Ranier's Compounding Laboratory Recalls DMSO 6.25% Opth Sol for Sterility Concerns
Ranier's Compounding Laboratory is recalling DMSO 6.25% Opth Sol due to a lack of assurance of sterility. The product was distributed within Pennsylvania.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the rubric specifies that FDA Class II recalls with potential for significant injury or hospitalization (implied by sterility failure in a sterile product) fall under the Severe category.
Plain-English summary
Ranier's Compounding Laboratory is recalling DMSO 6.25% Opth Sol, 10 mL droptainer, prescription only. The recall is due to a lack of assurance of sterility, as practices at the firm may call into question the sterility of products intended to be sterile.
The affected product was distributed within the state of Pennsylvania. All lots within expiry are included in this recall.
Consumers who have this product should contact their healthcare provider or pharmacist for instructions on how to dispose of it or obtain a replacement.
The recalled product
- Product
- DMSO 6.25% Opth Sol, 10 mL droptainer, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.
- Manufacturer
- Ranier's Compounding Laboratory
- Hazard
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 15 recalled by Ranier's Compounding Laboratory under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 15 products in this recall →Related recalls
Same manufacturer · Ranier's Compounding Laboratory
See all →- SevereRanier's Compounding Laboratory Recalls Acetylcysteine 10% Ophthalmic Solution
FDA (Drugs) · 2018-08-22
- SevereRanier's Compounding Laboratory Recalls Vitamin D3 Injection Due to Sterility Concerns
FDA (Drugs) · 2018-08-22
- SevereRanier's Compounding Laboratory Recalls Atropine 0.01% Opth Solution
FDA (Drugs) · 2018-08-22
- SevereRanier's Triple P Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2018-08-22
- SevereRanier's PR/PA/PH Injection Recalled for Sterility Concerns
FDA (Drugs) · 2018-08-22
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereRed Mountain Compounding Recalls S-DMSO Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2019-11-13
- SevereSpecialty Medicine Compounding Pharmacy Recalls EDETATE DISODIUM Ophthalmic Solution
FDA (Drugs) · 2014-01-22
- SevereKey Pharmacy Recalls DMSO 6.25% Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- High5-Fluorouracil Ophthalmic Solution Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2023-02-01
- HighEdetate Disodium Ophthalmic Solution Recalled for Sterility Concerns
FDA (Drugs) · 2023-02-01
- SevereNora Apothecary Recalls Dexamethasone Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2013-06-05